Clinical predictors of steroid-induced exacerbation in myasthenia gravis

Journal of Clinical Neuroscience

Volumn 13, Issue 10, 2006, Pages 1006-1010

  Bae, Jong Seok ^a   Go, Seok Min ^a   Kim, Byoung Joon ^b  

^a Seoul Medical Center   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Exacerbation; Myasthenia gravis; Predictor; Prednisone; Steroids

Indexed keywords

PREDNISONE;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY WEIGHT; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HUMAN; KOREA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYASTHENIA GRAVIS; PREDICTION; PRIORITY JOURNAL;

ADULT; AGE FACTORS; ANTI-INFLAMMATORY AGENTS; BRAIN STEM; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MYASTHENIA GRAVIS; NEUROMUSCULAR JUNCTION; PREDICTIVE VALUE OF TESTS; PREDNISONE; RISK ASSESSMENT; RISK FACTORS;

EID: 33751006995     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2005.12.041     Document Type: Article

References (22)

1. Younger D.S., and Raksadawan N. Therapy in neuromuscular disease. Neurol Clin 19 (2001) 205-215
2. Simon H.E. Myasthenia gravis: Effect of treatment with anterior pituitary extract. JAMA 104 (1935) 2065-2066
3. Torda C., and Wolff H.G. Effects of adrenocorticotropic hormone on neuromuscular function in patients with myasthenia gravis. Proc Soc Exp Biol Med 71 (1949) 432-435
4. Torda C., and Wolff H.G. Effects of adrenocorticotropic hormone on neuromuscular function in patients with myasthenia gravis. J Clin Invest 28 (1949) 1228-1235
5. Chung C.S., and Myung H.J. A clinical study on crisis in myasthenia gravis. J Korean Neurol Assoc 2 (1984) 29-39
6. Jenkins R.B. Treatment of myasthenia gravis with prednisone. Lancet 1 (1972) 765-767
7. Brunner N.G., Namba T., and Grob D. Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy. Neurology 22 (1972) 603-610
8. Osserman K.E. Myasthenia Gravis (1958), Grune & Stratton, New York
9. Rosenfeld J., and Jackson C.E. Quantitative assessment and outcome measures in neuromuscular disease. In: Katirji B., Kaminski H.J., Preston D.C., et al. (Eds). Neuromuscular Disorders in Clinical Practice. 1st ed. (2002), Butterworth-Heinemann, Woburn 309-343
10. Richman D.P., and Agius M.A. Treatment of autoimmune myasthenia gravis. Neurology 61 (2003) 1652-1661
11. Jenkins R.B. Treatment of myasthenia gravis with prednisone. Lancet 1 (1972) 765-767
12. Seybold M.E., and Drachman D.B. Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment. N Engl J Med 290 (1974) 81-84
13. Namba T., Brunner N.G., and Grob D. Myasthenia gravis in patients with thymoma, with particular reference to onset after thymectomy. Medicine (Baltimore) 57 (1978) 411-433
14. Freydberg L.D. The place of corticotropin in the treatment of myasthenia gravis. Ann Intern Med 52 (1960) 806-818
15. Fuchs S., Bartfeld D., Eshhar Z., et al. Immune regulation of experimental myasthenia. J Neurol Neurosurg Psychiatry 43 (1980) 634-643
16. Drachman D.B. Myasthenia gravis. N Engl J Med 330 (1994) 1797-1810
17. Durelli L., Maggi G., Casadio C., et al. Actuarial analysis of the occurrence of remissions following thymectomy for myasthenia gravis in 400 patients. J Neurol Neurosurg Psychiatry 54 (1991) 406-411
18. Bedlack R.S., and Sanders D.B. Steroid treatment for myasthenia gravis: steroids have an important role. Muscle Nerve 25 (2002) 117-121
19. Simpson J.F., Westerberg M.R., and Magee K.R. Myasthenia gravis. An analysis of 295 cases. Acta Neurol Scand 42 Suppl.23 (1966) 21-27
20. Tindall R.S., Rollins J.A., Phillips J.T., et al. Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis. N Engl J Med 316 (1987) 719-724
21. Warmolts J.R., and Engel W.K. Benefit from alternate-day prednisone in myasthenia gravis. N Engl J Med 286 (1972) 17-20
22. Kjaer M. Myasthenia gravis and myasthenic syndromes treated with prednisone. Acta Neurol Scand 47 (1971) 464-474